Country: Ġermanja
Lingwa: Ingliż
Sors: HMA (Heads of Medicines Agencies)
marbofloxacin 50 mg/ml
Vetoquinol S.A.
Tablet
Cattle Young
2008-10-19
1/4 1. NAM E OF THE VETERINARY M EDICINAL PRODUCT MARBOCYL BOLUS 50 mg tablets for calves 2. QUALITATIVE AND QUANTITATIVE COM POSITION Marbofloxacin ................................................... 50.00 mg Excipient QSP ................................................... 1500 mg For a full list of excipients, see section 6.1. 3. PHARM ACEUTICAL FORM Tablet Off white bolus shaped convex tablet. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Calves 4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES In neonatal calves: Treatment of gastroenteritis caused by sensitive strains of _Escherichia coli_ K99+. 4.3 CONTRAINDICATIONS Bacterial infections with resistance to other fluoroquinolones (cross resistance) Do not administer to an animal previously found to be hypersensitive to marbofloxacine or other quinolone, or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Refer to statements under Sections 4.3 and 4.5. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing official and local antimicrobial policies should be taken into account whe n the product is used. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistanc Aqra d-dokument sħiħ